Literature DB >> 26622842

Association between functional variants in BIRC5/survivin gene 3' untranslated region and mRNA expression in lymphoblastoid cell lines.

Feifei Pu1, Zengwu Shao1, Shuhua Yang1, Jianxiang Liu1, Song Lin1, Xiucai Ma1, Haofei Yang1.   

Abstract

Baculoviral inhibitor of apoptosis repeat-containing 5 (BIRC5)/survivin genetic microRNA (miRNA) binding site variants in the 3' untranslated region (3'UTR) are known to be significantly associated with cancer risk. However, the roles of genetic variants in BIRC5/survivin gene 3'UTRs and post-transcriptional regulation have not been elucidated. In the present study, we revealed that rs1042489, rs1042542, rs17882360, rs2239680, rs2661694 and rs4789560 in the BIRC5/survivin 3'UTR have potential miRNA binding sites using bioinformatics analysis. However, only rs1042489 was significantly associated with BIRC5/survivin mRNA expression in lymphoblastoid cell lines (P=0.030); rs1042489 may be a putative variant mediating the post-transcriptional regulation of the target BIRC5/survivin gene. An in-depth understanding of how 3'UTR variants regulate BIRC5/survivin activity is expected to pave the way to targeting the BIRC5/survivin pathway in cancer therapy.

Entities:  

Keywords:  baculoviral inhibitor of apoptosis repeat-containing 5; genetic; microRNA; polymorphisms; survivin; variant

Year:  2015        PMID: 26622842      PMCID: PMC4579978          DOI: 10.3892/ol.2015.3507

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  13 in total

1.  [Arf6, RalA and BIRC5 protein expression in non small cell lung cancer].

Authors:  A V Knizhnik; O B Kovaleva; K K Laktionov; V V Mochal'nikova; A V Komel'kov; E M Chevkina; I B Zborovskaia
Journal:  Mol Biol (Mosk)       Date:  2011 Mar-Apr

2.  Investigation of cell free BIRC5 mRNA as a serum diagnostic and prognostic biomarker for colorectal cancer.

Authors:  Haiyan Wang; Xin Zhang; Lili Wang; Guixi Zheng; Lutao Du; Yongmei Yang; Zhaogang Dong; Yimin Liu; Ailin Qu; Chuanxin Wang
Journal:  J Surg Oncol       Date:  2013-12-11       Impact factor: 3.454

3.  Prognostic and clinicopathological significance of survivin expression in bladder cancer patients: a meta-analysis.

Authors:  Shunzeng Lv; Ekaterina Turlova; Shigang Zhao; Huihui Kang; Mingzhi Han; Hong-Shuo Sun
Journal:  Tumour Biol       Date:  2013-10-08

4.  Prognostic impact of polymorphisms in the MYBL2 interacting genes in breast cancer.

Authors:  Hong Shi; Melanie Bevier; Robert Johansson; Kerstin Enquist-Olsson; Roger Henriksson; Kari Hemminki; Per Lenner; Asta Försti
Journal:  Breast Cancer Res Treat       Date:  2011-10-26       Impact factor: 4.872

5.  Relative impact of nucleotide and copy number variation on gene expression phenotypes.

Authors:  Barbara E Stranger; Matthew S Forrest; Mark Dunning; Catherine E Ingle; Claude Beazley; Natalie Thorne; Richard Redon; Christine P Bird; Anna de Grassi; Charles Lee; Chris Tyler-Smith; Nigel Carter; Stephen W Scherer; Simon Tavaré; Panagiotis Deloukas; Matthew E Hurles; Emmanouil T Dermitzakis
Journal:  Science       Date:  2007-02-09       Impact factor: 47.728

Review 6.  Survivin--prognostic tumor biomarker in human neoplasms--review.

Authors:  Joanna Waligórska-Stachura; Anna Jankowska; Ryszard Waśko; Wlodzimierz Liebert; Maciej Biczysko; Agata Czarnywojtek; Daria Baszko-Błaszyk; Violet Shimek; Marek Ruchała
Journal:  Ginekol Pol       Date:  2012-07       Impact factor: 1.232

7.  Strong expression of survivin is associated with positive response to radiotherapy and improved overall survival in head and neck squamous cell carcinoma patients.

Authors:  Lovisa Farnebo; Katharina Tiefenböck; Anna Ansell; Lena K Thunell; Stina Garvin; Karin Roberg
Journal:  Int J Cancer       Date:  2013-05-09       Impact factor: 7.396

8.  SNPexp - A web tool for calculating and visualizing correlation between HapMap genotypes and gene expression levels.

Authors:  Kristian Holm; Espen Melum; Andre Franke; Tom H Karlsen
Journal:  BMC Bioinformatics       Date:  2010-12-17       Impact factor: 3.169

9.  Cell cycle genes and ovarian cancer susceptibility: a tagSNP analysis.

Authors:  J M Cunningham; R A Vierkant; T A Sellers; C Phelan; D N Rider; M Liebow; J Schildkraut; A Berchuck; F J Couch; X Wang; B L Fridley; A Gentry-Maharaj; U Menon; E Hogdall; S Kjaer; A Whittemore; R DiCioccio; H Song; S A Gayther; S J Ramus; P D P Pharaoh; E L Goode
Journal:  Br J Cancer       Date:  2009-09-08       Impact factor: 7.640

10.  BIRC5 expression is a poor prognostic marker in Ewing sarcoma.

Authors:  Pooja Hingorani; Paul Dickman; Pamela Garcia-Filion; Andrea White-Collins; Edward A Kolb; David O Azorsa
Journal:  Pediatr Blood Cancer       Date:  2012-09-07       Impact factor: 3.838

View more
  4 in total

1.  Von Hippel-Lindau gene single nucleotide polymorphism (rs1642742) may be related to the occurrence and metastasis of HBV-related hepatocellular carcinoma.

Authors:  Xuebing Chen; Hao Zhang; Shimei Ou; Huijuan Chen
Journal:  Medicine (Baltimore)       Date:  2021-09-03       Impact factor: 1.817

2.  The Effect of Botulinum Toxin Type A on Expression Profiling of Long Noncoding RNAs in Human Dermal Fibroblasts.

Authors:  Ying-Ying Miao; Juan Liu; Jie Zhu; Yan-Ling Tao; Jia-An Zhang; Dan Luo; Bing-Rong Zhou
Journal:  Biomed Res Int       Date:  2017-02-07       Impact factor: 3.411

3.  Regulation of Survivin Isoform Expression by GLI Proteins in Ovarian Cancer.

Authors:  Diana Trnski; Maja Gregorić; Sonja Levanat; Petar Ozretić; Nikolina Rinčić; Tajana Majić Vidaković; Držislav Kalafatić; Ivana Maurac; Slavko Orešković; Maja Sabol; Vesna Musani
Journal:  Cells       Date:  2019-02-06       Impact factor: 6.600

4.  BIRC5 Gene Disruption via CRISPR/Cas9n Platform Suppress Acute Myelocytic Leukemia Progression

Authors:  Manizheh Narimani; Mohammadreza Sharifi; Mohammad Saeed Hakhamaneshi; Daem Roshani; Mohammad Kazemi; Seyed Hossein Hejazi; Ali Jalili
Journal:  Iran Biomed J       Date:  2019-05-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.